Literature DB >> 16612621

Myocardial sleeves of pulmonary veins and atrial fibrillation: a postmortem histopathological study of 100 subjects.

Ivo Steiner1, Petra Hájková, Jirí Kvasnicka, Ivana Kholová.   

Abstract

Atrial fibrillation (AF) is triggered by ectopic beats originating from extensions of the left atrial myocardium over the pulmonary veins (PVs), so-called myocardial sleeves. A total of 100 hearts (393 PVs) obtained at autopsy were studied. Of these, 50 were from patients with chronic AF and 50 from controls in sinus rhythm. Out of a total of 393 PVs studied, a sleeve was present in 349 PVs (88.8%). The myocardial sleeves frequently harboured senile atrial amyloid and scarring. These two changes were evaluated semi-quantitatively (grade 0-3). Amyloidosis was found in 68% of all hearts and in 55% of all sleeves. It was more frequent in patients with AF (58.5%) than in those without (51.7%), however, without statistical significance (p values 0.948, 0.306, 0.166 and 1). Scarring was present in all 349 sleeves studied. It was significantly more severe in patients with AF (average grade 2.44) than in those without (average grade 2.00) (p values <0.001, <0.1, <0.05 and <0.01). In conclusion, amyloidosis and particularly scarring of the myocardial sleeves of the pulmonary veins, appear to be common in the elderly population as an arrhythmogenic substrate for AF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612621     DOI: 10.1007/s00428-006-0197-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  46 in total

Review 1.  Pathophysiology and prevention of atrial fibrillation.

Authors:  M A Allessie; P A Boyden; A J Camm; A G Kléber; M J Lab; M J Legato; M R Rosen; P J Schwartz; P M Spooner; D R Van Wagoner ; A L Waldo
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  Pulmonary veins-left atrial junction: anatomic and histological study.

Authors:  J B Moubarak; J V Rozwadowski; C T Strzalka; W R Buck; W S Tan; G F Kish; T Kisiel; H C Fronc; J D Maloney
Journal:  Pacing Clin Electrophysiol       Date:  2000-11       Impact factor: 1.976

3.  Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure.

Authors:  Fumiki Yoshihara; Toshio Nishikimi; Yoshikado Sasako; Jun Hino; Junjiro Kobayashi; Kenji Minatoya; Ko Bando; Yoshio Kosakai; Takeshi Horio; Shin-ichi Suga; Yuhei Kawano; Hiroaki Matsuoka; Chikao Yutani; Hisayuki Matsuo; Soichiro Kitamura; Tohru Ohe; Kenji Kangawa
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

Review 4.  Why does atrial fibrillation occur?

Authors:  M J Janse
Journal:  Eur Heart J       Date:  1997-05       Impact factor: 29.983

Review 5.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

6.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

7.  Amyloid peptides are toxic via a common oxidative mechanism.

Authors:  D Schubert; C Behl; R Lesley; A Brack; R Dargusch; Y Sagara; H Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation.

Authors:  Rutger J Hassink; H Thomas Aretz; Jeremy Ruskin; David Keane
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

Review 9.  Cardiac arrhythmias: the quest for a cure: a historical perspective.

Authors:  Hein J J Wellens
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

10.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  10 in total

1.  Atria Depolarization in Rats with Alcoholic Cardiomyopathy.

Authors:  S L Smirnova; I M Roshchevskaya; M P Roshchevsky; I B Tsorin; V N Stolyaruk; M B Vititnova; L G Kolik; S A Kryzhanovskii
Journal:  Dokl Biol Sci       Date:  2018-05-22

Review 2.  Association of Left Atrial Fibrosis Detected by Delayed Enhancement Magnetic Resonance Imaging and Risk of Stroke in Patients with Atrial Fibrillation.

Authors:  Dana C Peters
Journal:  J Atr Fibrillation       Date:  2011-07-15

Review 3.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

4.  Relationship between Atrial Tissue Remodeling and ECG Features in Atrial Fibrillation.

Authors:  Li-Ya Rao; Yi Mao; Kun Huang; Yu-Shu Li; Yan-Wen Shu
Journal:  Curr Med Sci       Date:  2019-07-25

5.  Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers.

Authors:  Dana C Peters; Jérôme Lamy; Albert J Sinusas; Lauren A Baldassarre
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-12-18       Impact factor: 6.875

6.  Human Pulmonary Vein Myocardial Sleeve Autonomic Neural Density and Cardiovascular Mortality.

Authors:  Denis Depes; Ari Mennander; Rauha Vehniäinen; Timo Paavonen; Ivana Kholová
Journal:  J Histochem Cytochem       Date:  2022-09-24       Impact factor: 4.137

7.  Current treatment in cardiac amyloidosis.

Authors:  Ivana Kholová; Josef Kautzner
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

8.  EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  J Arrhythm       Date:  2016-07-11

Review 9.  Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation.

Authors:  Damián Sánchez-Quintana; José Ramón López-Mínguez; Gonzalo Pizarro; Margarita Murillo; José Angel Cabrera
Journal:  Curr Cardiol Rev       Date:  2012-11

10.  Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation.

Authors:  Jordan K Boutilier; Rhonda L Taylor; Tracy Mann; Elyshia McNamara; Gary J Hoffman; Jacob Kenny; Rodney J Dilley; Peter Henry; Grant Morahan; Nigel G Laing; Kristen J Nowak
Journal:  G3 (Bethesda)       Date:  2017-09-07       Impact factor: 3.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.